long intergenic non-protein coding RNA 2561Genealiases: []
Q-omics provides the consensus-scored LINC02561 profile across patient tissues and cancer cell-line models. LINC02561 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC02561 is differentially expressed in 14, with the highest sampling consensus in HNSC. Additionally, LINC02561 RNA expression shows 14,574 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight UVM, HNSC, and LSCC as cancer lineages where LINC02561 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02561 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02561 survival associations across molecular data types. LINC02561 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02561 RNA expression–survival associations across cancer types. High LINC02561 expression shows unfavorable associations in UVM, LIHC, HNSC, KIRP and LUAD, but favorable associations in SKCM. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify UVM as the clearest survival context for LINC02561 RNA expression.
This table summarizes LINC02561 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02561. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02561 shows higher tumor expression in HNSC, KIRP, LIHC, KIRC, READ and STAD. The HNSC box plot shows higher LINC02561 RNA expression in tumor versus normal tissue (log2 FC = +1.129, t-test p < 0.001).
This table shows molecular features associated with LINC02561 in patient tissues and cancer cell lines. In patient samples, LINC02561 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
